Hospi Corporation(RHP)

Focus: Hospi Corporation is a publicly traded medical device company headquartered in Nashville, TN, specializing in catheter technology with $2.2B in FY 2025 revenue.

Profile data last refreshed 19h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Hospi Corporation

AI assessmentNot Hiring

No open roles listed right now. Follow Hospi Corporation to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$2.2B

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

SEC Filings: 2 available

Financials (FY2025)

Help build intelligence for Hospi Corporation

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Strong financial momentum: revenue grew 22% YoY ($1.8B to $2.2B) with net income more than doubling to $311M
Solid cash position of $592M provides stability for long-term R&D and strategic initiatives
Public company scale with established market presence in high-demand catheter/medical device sector

Watch Out For

Zero active clinical trials and no disclosed pipeline programs suggest limited innovation velocity in drug development
No current job openings listed and unknown headcount makes hiring prospects unclear

Generated by Claude from Hospi Corporation's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo